Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use. Viral vectors must be free of contaminants, such as adventitious ...

Kite Pharma's viral vector plant in Southern California has been cleared for liftoff, and, with that, the Gilead Sciences company is touting its position as the only cell therapy player able to make ...

At AI Dev 26 x SF today, Actian, the data and AI division of HCLSoftware, announced Actian VectorAI DB, a portable vector database purpose-built to power production AI in regulated, disconnected, and ...

The use of viral vectors as gene delivery and vaccine vehicles has developed rapidly during the last two decades owing to several viral properties. Viruses can infect cells efficiently, often have a ...